Inhibitory molecules such as PD-1, LAG3, and CTLA4 on Treg cells serve important roles in suppressing the activation of nearby immune cells and represent perturbation targets to unleash anti-tumor immunity. The gene discussed is CTLA4; the disease is neoplasm.